19
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Effects of Mitomycin-C and Etoposide in Cell Culture and in Nude Mice: The Role of G-CSF Mutein

, , , , &
Pages 283-290 | Published online: 11 Jun 2009

References

  • Kish Drelichman J., Jacobs A., Hoschner J., Kinzie J., Loh J., Weaver J. A, Al-Sarraf M. Clinical trial of cisplatin and 5-FU as initial treatment for advanced squamous cell carcinoma of thc head and neck. Cancer Treat Rep 1982; 66: 471–474
  • Wolf G T. An overview of preoperative chemotherapy: Where do we go from here. Am J Otolaryngol 1984; 5: 77–79
  • Tannock I F, Browman G. Lack of evidence for a rolc of cheniotherapy in the routine management of locally advanced head and neck cancer. J Clin Oncol 1986; 4: 1121–1126
  • Taylor SG, IV. Why has so much chemotherapy done so little in head and neck cancer. J Clin Oncol 1987; 5: 1–3
  • Adjuvant chemotherapy for advanced head and neck squanous carcinoma. Final report of the head and neck contracts program. Cancer 1987; 60: 301–311
  • Crooke S, Bradner W. Mitomycin C: A review. Cancer Treat Rev 1976; 3: 121–129
  • Leyvraz S, Barrelet Savary L. M, Bernasconi S. Combination of mitomycin, vindesine and cisplatin in the treatment of head and neck squamous cell carcinoma. Cancer Treat Rep 1987; 71: 81–82
  • Greenberg S M, Felman IE., Gala K V, Johnson KB., Owens J C. Phase II study of etoposide (VP-16) in the treatment of advanced head and neck cancer. Am J Clin Oncol 1985; 8: 393–395
  • Keyes S R, Heimbrook D, Fracasso C. P, Rockwcll M. S., Sligar S G, Sartorelli A C. Chemotherapeutic attack of hypoxic tumor cells by the hioreductive alkylating agent mitomycin-C. Adv Enzyme Regul 1985; 23: 291–307
  • Rose W, Bradner C. WT. In vivo experimental antitumor activity of etoposide. Etoposide (VP-16). Current Status and New Developments, BF Issell, FM Muggia, SK Carter. Academic Press, Orlando 1984; 33–47
  • Sutherland R M, Durand R E. Growth and cellular characteristics of multicell spheroids. Recent Results Cancer Res 1984; 95: 24–48
  • Kohno N, Ohnuma T, Biller H, Holland J F. Effects of cisplatin plus 5-fluorouracil vs cisplatin plus cytarabine on head and neck squamous multicellular tumor spheroids. Arch Otolaryngol Head Neck Sure 1988; 144: 157–161
  • Sasaki T, Yamamoto M, Yamaguchi T, Sugiyama S. Development of multicellularspheroids of HeLa cells cocultured with fibroblasts and their X-irradiation. Cancer Res 1984; 44: 345–351
  • Kerr D J, Wheldon T E, Ken A M, Freshney R I, Kaye S B. The effect of adriamycin and 4′deoxydoxorubicin on cell survival of human lung tumor cells grown in monolayer and as spheroids. Br J Cancer 1986; 54: 423–429
  • Erlichman C, Vidgen D. Cytotoxicity of adriamycin in MGH-UI cells grown as monolayer cultures, spheroids and xenografts in immune-deprived mice. Cancer Res 1984; 44: 5369–5375
  • Durand R E. Flow cytometry studies of intracellular adriamycin in multicell spheroids in vitro. Cancer Res 1981; 41: 3495–3498
  • Yuhas J M, Li A P, Martinez A O, Ladman A J. A simplified method for production and growth of multicellular tumor spheroids. Cancer Res 1977; 37: 3639–3643
  • Yuhas J M, Tarleton A E, Molzen K B. Multicellular tumor spheroid formation by breast cancer cells isolated from different sites. Cancer Res 1978; 38: 2486–2491
  • Kuroki T. Colony formation of mammalian cells of agar plates and its application to Lederberg's replica plating. Exp Cell Res 1974; 805–62
  • Chou T C, Talalay P. Quantitative analysis of dose-effect relationships The combined effects of multidrug or enzyme inhibitors. Adv Enzyme Regul 1984; 22: 27–55
  • Chou T C. New computerized quantitative approach to combination therapy. Proc Am Assoc Cancer Res 1985; 26: 341
  • Looney W B, Mayo A A, Allen P M. A mathematical evaluation of tumor growth curves in rapid, intermediate and slow growing rat hepatoma. Br J Cancer 1973; 27: 341–344
  • Itoh S, Kuga T, Komatsu Y, Sekine S, Miyaji H, Nishi T, Saito Kamazaki M. M, Yokoo T, Okdbe T, Morimoto M. Production of mutains of human granulocyte colony stimulating factor (HG-CSF) with increased biological activity. XXll Congress of the International Society of Hematology. Ferrari Brothers Graphic Arts, Milan 1988; 158
  • Piao Y-F, Okabe T. Receptor binding of human granulocyte colony-stimulating factor to the blast cells of myeloid leukemia. Cancer Res 1990; 50: 1671–1674
  • Wu L, Fujii M, Ohnuma T. Penetration and drug interaction of mitomycin-C in MCF-7 multicellular tumor spheroids. Proc Am Assoc Cancer Res 1990; 31: 390
  • Griswol DP, Jr, Trader M W, Frei E, III, Peters W P, Wolpert M K, Laster WR, Jr. Response of drug-sensitive and-resistant L1210 leukemias to high-dose chemotherapy. Cancer Res 1987; 47: 2323–2327
  • Farha P, Spitzer G, Valdivieso M. High dose chemotherapy and autologous bone marrow transplantation for the treatment of small cell lung carcinoma. Cancer 1983; 52: 1351–1355
  • Postmus P, Mulder N H, Hospers H GV, Mulder P M, Maas A, Meinesz A F, Sleijfer D T, Vries E GE. High-dose cyclophospha-mide and high-dose VP16–213 for recurrent or refractory small cell lung cancer, a phase II study. Eur J Cancer Oncol 1985; 21: 1467–1470
  • Issell B, Rudolph F. AR., Louie A C. Etoposide (VP-16–213): An overview. Etoposide (VP-16). Current Status and New Developments, BF Issell, FM Muggia, SK Carter. Academic Press, Orlando 1984; 1–13
  • Talmadge J E, Tribble H, Pennington R, Bowersox O, Schneider M A, Castelli P, Black P L, Abe F. Protective, restorative and therapeutic properties of recombinant colony-stimulating factors. Blood 1989; 73: 2093–2103
  • Shimamura M, Kobayashi Y, Yuo A, Urabe A, Okabe T, Komatsu Y, Itoh S, Takaku F. Effect of human recombinant granulocyte colony-stimulating factor on hematopoietic injury in mice induced by 5-fluorouracil. Blood 1987; 69: 353–355
  • Gabrilove J L, Jakubowski A, Sher H, Sternberg C, Wong G, Grous J, Yagoda A, Fain K, Moore M AS, Clarkson B, Oettgen H F, Alton K, Welte K, Souza L. Effect of granulocyte colony-stimulating factor on neutropenia and Associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium. N Engl J Med 1988; 318: 1414–1422
  • Bronchud M H, Scarffe J H, Thacher N, Crowther D, Souza L M, Alton N K, Testa N G, Dexter T M. Phase 1/11 study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer. Br J Cancer 1987; 56: 809–813
  • Morstyn G, Campbell L, Souza L M, Alton N K, Keech L, Green M, Sheridan W, Metcalf D. Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy. Lancet 1988; 26: 667–671

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.